← Back
$GILD All transactions

GILEAD SCIENCES, INC.

F

$ Value

$158K

Shares

1,063

Price

$149

Filed

Mar 12

Insider

Name

Berger Dietmar

Title

Chief Medical Officer

CIK

0001739515

Roles

Officer

Transaction Details

Transaction Date

2026-03-10

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

18,982

Footnotes

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. | The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Filing Info

Accession No.

0001739515-26-000006

Form Type

4

Issuer CIK

0000882095

Berger Dietmar's History

Date Ticker Type Value
2026-03-10 GILD M
2026-03-10 GILD F $158K
2026-03-10 GILD M
2026-03-10 GILD A
2026-03-10 GILD A $0
2026-02-27 GILD A $0
2026-01-02 GILD M
2026-01-02 GILD F $844K
2026-01-02 GILD M

Other Insiders at GILD (90d)

Insider Bought Sold Last
Dickinson Andrew D
Chief Financial Officer
$463K 2026-03-10
Dickinson Andrew D / Mercier Johanna
Chief Financial Officer
$856K 2026-04-15
O'Day Daniel Patrick
Chairman & CEO
$21.6M 2026-03-27
Berger Dietmar
Chief Medical Officer
2026-03-10
Mercier Johanna
Chief Comm & Corp Aff Officer
$4.3M 2026-03-10
Burkhart Erin
SVP, Controllership
2026-03-10
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
2026-03-10